FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307636819> ?p ?o ?g. }

• W4307636819 endingPage "3467" @default.
• W4307636819 startingPage "3459" @default.
• W4307636819 abstract "Neuropathic pain is a widespread problem with a big impact on quality of life. The currently used drug regimens are often insufficiently effective or cause - sometimes unacceptable - side effects. Intravenous lidocaine could be an alternative treatment, by blocking spontaneous depolarization and hyperexcitability in upregulated sodium channels in nociceptors. Research so far has shown varying results but the treatment protocols differed a lot and follow-up was usually short. In our hospital, lidocaine infusions have been applied for many years in a unique treatment protocol consisting of a relatively high dose of lidocaine (1000 mg) administered over 25 hours. Our aim is to share information on both the efficacy and safety of this treatment schedule.We conducted a retrospective cohort study in all patients who received a lidocaine infusion between January 2014 and January 2018. The standard infusion protocol consists of a total of 1000 mg lidocaine administered intravenously during 25 hours (40 mg/hour). Pain diagnoses were stratified into 15 groups, in agreement with diagnoses used in daily practice. Effectiveness of the treatment was classified as effect or no effect based on the description found in the chart.We included 282 patients, with a median age of 58 years and 64% of whom were female. Patients with myofascial pain syndrome, peripheral (mono)neuropathy, small fiber neuropathy and vascular disease benefited most. Patients with cancer pain, postherpetic neuralgia, chemotherapy-induced neuropathy and radicular pain showed the least pain improvement. There were no serious adverse events.In selected patients, lidocaine infusions may be a safe and efficacious treatment for chronic neuropathic pain. More prospective research is needed to further determine the optimal dosing, duration and interval of lidocaine infusion therapy, and to better understand in which specific patient categories this treatment is most beneficial." @default.
• W4307636819 created "2022-11-04" @default.
• W4307636819 creator A5073242961 @default.
• W4307636819 creator A5078953133 @default.
• W4307636819 creator A5085062456 @default.
• W4307636819 date "2022-10-01" @default.
• W4307636819 modified "2023-10-14" @default.
• W4307636819 title "Intravenous Lidocaine for Treatment of Chronic Pain: A Retrospective Cohort Study" @default.
• W4307636819 cites W1500868300 @default.
• W4307636819 cites W1966053536 @default.
• W4307636819 cites W1968126783 @default.
• W4307636819 cites W1971020268 @default.
• W4307636819 cites W1976712777 @default.
• W4307636819 cites W1978608725 @default.
• W4307636819 cites W1986782242 @default.
• W4307636819 cites W1988151511 @default.
• W4307636819 cites W1991882165 @default.
• W4307636819 cites W2008550582 @default.
• W4307636819 cites W2019406234 @default.
• W4307636819 cites W2020224172 @default.
• W4307636819 cites W2027010723 @default.
• W4307636819 cites W2029572600 @default.
• W4307636819 cites W2033756221 @default.
• W4307636819 cites W2034595944 @default.
• W4307636819 cites W2038996387 @default.
• W4307636819 cites W2043299767 @default.
• W4307636819 cites W2048656464 @default.
• W4307636819 cites W2063070370 @default.
• W4307636819 cites W2063212852 @default.
• W4307636819 cites W2065008157 @default.
• W4307636819 cites W2067320018 @default.
• W4307636819 cites W2068531345 @default.
• W4307636819 cites W2069703108 @default.
• W4307636819 cites W2076964900 @default.
• W4307636819 cites W2077069417 @default.
• W4307636819 cites W2078200446 @default.
• W4307636819 cites W2079038140 @default.
• W4307636819 cites W2081566651 @default.
• W4307636819 cites W2081881541 @default.
• W4307636819 cites W2084567915 @default.
• W4307636819 cites W2093322674 @default.
• W4307636819 cites W2104818454 @default.
• W4307636819 cites W2124824246 @default.
• W4307636819 cites W2127894556 @default.
• W4307636819 cites W2145732412 @default.
• W4307636819 cites W2146558764 @default.
• W4307636819 cites W2149004084 @default.
• W4307636819 cites W2149813500 @default.
• W4307636819 cites W2153767222 @default.
• W4307636819 cites W2154536095 @default.
• W4307636819 cites W2154637671 @default.
• W4307636819 cites W2159609548 @default.
• W4307636819 cites W2160816722 @default.
• W4307636819 cites W2161563980 @default.
• W4307636819 cites W2168750649 @default.
• W4307636819 cites W2171516791 @default.
• W4307636819 cites W2201880635 @default.
• W4307636819 cites W2741464172 @default.
• W4307636819 cites W2783969794 @default.
• W4307636819 cites W2906596360 @default.
• W4307636819 cites W2907444629 @default.
• W4307636819 cites W2969879572 @default.
• W4307636819 cites W3143970644 @default.
• W4307636819 cites W4236958887 @default.
• W4307636819 cites W4243212098 @default.
• W4307636819 doi "https://doi.org/10.2147/jpr.s379208" @default.
• W4307636819 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36329833" @default.
• W4307636819 hasPublicationYear "2022" @default.
• W4307636819 type Work @default.
• W4307636819 citedByCount "2" @default.
• W4307636819 countsByYear W43076368192023 @default.
• W4307636819 crossrefType "journal-article" @default.
• W4307636819 hasAuthorship W4307636819A5073242961 @default.
• W4307636819 hasAuthorship W4307636819A5078953133 @default.
• W4307636819 hasAuthorship W4307636819A5085062456 @default.
• W4307636819 hasBestOaLocation W43076368191 @default.
• W4307636819 hasConcept C126322002 @default.
• W4307636819 hasConcept C141071460 @default.
• W4307636819 hasConcept C167135981 @default.
• W4307636819 hasConcept C197934379 @default.
• W4307636819 hasConcept C2777107010 @default.
• W4307636819 hasConcept C2778866549 @default.
• W4307636819 hasConcept C2780149897 @default.
• W4307636819 hasConcept C42219234 @default.
• W4307636819 hasConcept C71924100 @default.
• W4307636819 hasConcept C72563966 @default.
• W4307636819 hasConceptScore W4307636819C126322002 @default.
• W4307636819 hasConceptScore W4307636819C141071460 @default.
• W4307636819 hasConceptScore W4307636819C167135981 @default.
• W4307636819 hasConceptScore W4307636819C197934379 @default.
• W4307636819 hasConceptScore W4307636819C2777107010 @default.
• W4307636819 hasConceptScore W4307636819C2778866549 @default.
• W4307636819 hasConceptScore W4307636819C2780149897 @default.
• W4307636819 hasConceptScore W4307636819C42219234 @default.
• W4307636819 hasConceptScore W4307636819C71924100 @default.
• W4307636819 hasConceptScore W4307636819C72563966 @default.
• W4307636819 hasLocation W43076368191 @default.
• W4307636819 hasLocation W43076368192 @default.

• next